Short Interest in Arkema SA (OTCMKTS:ARKAY) Grows By 559.9%

Arkema SA (OTCMKTS:ARKAY – Get Free Report) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 1,729 shares, an increase of 559.9% from the June 30th total of 262 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 3,426 shares, the short-interest ratio is presently 0.5 days.

Arkema Price Performance

Arkema stock opened at $63.54 on Monday. Arkema has a 52 week low of $56.28 and a 52 week high of $79.36. The stock has a market cap of $4.83 billion, a price-to-earnings ratio of 254.15 and a beta of 0.86. The company’s 50-day moving average price is $66.23 and its two-hundred day moving average price is $67.03. The company has a current ratio of 2.25, a quick ratio of 1.64 and a debt-to-equity ratio of 0.53.

Get Arkema alerts:

Arkema (OTCMKTS:ARKAY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.10. The company had revenue of $2.57 billion during the quarter, compared to analyst estimates of $2.52 billion. Arkema had a net margin of 0.46% and a return on equity of 4.06%. On average, analysts expect that Arkema will post 3.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ARKAY. Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Kepler Capital Markets lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 7th. Sanford C. Bernstein upgraded shares of Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. The Goldman Sachs Group lowered shares of Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Finally, Berenberg Bank downgraded shares of Arkema from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce”.

Check Out Our Latest Analysis on Arkema

About Arkema

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

See Also

• Five stocks we like better than Arkema
• RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
• These 4 Earnings Reports Expose the Market’s Growing Economic Divide
• Broadcom May Be the Biggest Winner From Alphabet’s Earnings
• Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.